FORTIS.NSライブシグナル | Getagraph.comで利益を最大化

Live Chart Being Loaded With Signals

Commentary (8 5月 2024 @ 15:20):

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally...

Stats
本日の出来高	531 893
平均出来高	1.34M
時価総額	344.45B
EPS	INR0 ( 2024-02-06 )
次の収益日	( INR1.940 ) 2024-05-21
Last Dividend	INR1.000 ( 2023-07-20 )
Next Dividend	INR0 ( N/A )
P/E	62.16
ATR14	INR0.360 (0.08%)

ボリューム相関

長: 0.05 (neutral)

短: -0.18 (neutral)

Signal:(50.578) Neutral

Fortis Healthcare Limited 相関

10 最も正の相関
NOVARTIND.NS	0.907
BAYERCROP.NS	0.901
PIONEEREMB.NS	0.901
BIOFILCHEM.NS	0.9
TNPETRO.NS	0.896
AJRINFRA.NS	0.896
FSC.NS	0.895
GANGAFORGE.NS	0.895
DIAMONDYD.NS	0.894
SUULD.NS	0.891

10 最も負の相関
TARMAT.NS	-0.888
HARIOMPIPE.NS	-0.864
CIGNITITEC.NS	-0.862
SOMATEX.NS	-0.861
KIRLFER.NS	-0.861
KAYNES.NS	-0.861
SIEMENS.NS	-0.858
ISMTLTD.NS	-0.856
SONATSOFTW.NS	-0.855
BSELINFRA.NS	-0.853

知っていましたか？

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関（1つの変数が増加すると、もう一方は減少する）、1は完全な正の相関（1つの変数が増加すると、もう一方も増加する）、0は相関がないことを示します（変数間に関係がない）。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Fortis Healthcare Limited 相関 - 通貨/商品

-0.88
( strong negative )

-0.22
( neutral )

-0.89
( strong negative )

0.27
( neutral )

-0.24
( neutral )

Fortis Healthcare Limited 財務諸表

Annual	2022
収益:	INR62.98B
総利益:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
収益:	INR62.98B
総利益:	INR35.31B (56.08 %)
EPS:	INR7.80

FY	2022
収益:	INR56.39B
総利益:	INR42.21B (74.85 %)
EPS:	INR10.46

FY	2021
収益:	INR40.09B
総利益:	INR21.65B (54.00 %)
EPS:	INR-1.450

Financial Reports:

No articles found.

Fortis Healthcare Limited Dividends

(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR1.000 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Fortis Healthcare Limited Dividend Information - No Dividend Player

Dividend Sustainability Score: 3.45 - low (14.69%) | Divividend Growth Potential Score: 2.29 - Decrease likely (54.30%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.000	2023-07-20
Last Dividend	INR1.000	2023-07-20
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.000	--
Avg. Dividend % Per Year	0.12%	--
Score	0.92	--
Div. Sustainability Score	3.45
Div.Growth Potential Score	2.29
Div. Directional Score	2.87	--

Next Divdend (Est)
(2024-05-08)

INR2.00 Estimate 2.50 %

Dividend Stability

0.20 Very Poor

Dividend Score

0.92

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2023	INR1.000	0.36%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TOUCHWOOD.NS	Dividend Junior	2023-09-22	Annually	6	0.15%
PGIL.NS	Dividend Junior	2023-09-01	Annually	17	1.08%
JINDALSAW.NS	Dividend Junior	2023-06-13	Annually	22	1.62%
DEEPAKNTR.NS	Dividend Junior	2023-07-27	Annually	14	0.25%
SKMEGGPROD.NS	Dividend Junior	2023-08-30	Sporadic	21	0.95%
MGEL.NS	Dividend Junior	2023-08-08	Annually	5	0.59%
HARSHA.NS	Dividend Junior	2023-09-20	Insufficient data to determine frequency	2	0.09%
BDL.NS	Dividend Junior	2023-09-20	Semi-Annually	7	1.17%
PTC.NS	Dividend Knight	2023-09-20	Annually	21	6.06%
KDDL.NS	Dividend Junior	2023-09-22	Annually	8	0.29%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0819	1.500	8.36	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0703	1.500	-0.330	-0.494	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	6.77	1.000	8.60	8.60	[3 - 30]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.80	2.00	5.60	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.553	1.000	4.12	4.12	[0.2 - 0.8]
operatingProfitMarginTTM	0.128	1.000	9.43	9.43	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	63.02	1.000	3.73	0	[1 - 100]
returnOnEquityTTM	0.0703	2.50	-0.212	-0.494	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
dividendYielPercentageTTM	0.217	1.500	4.58	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.80	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.219	1.500	-4.79	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0984	1.000	-0.0403	0	[0.1 - 0.5]
Total Score				2.29

Fortis Healthcare Limited

Fortis Healthcare Limited, an integrated healthcare delivery service provider, offers secondary, tertiary, and quaternary care in India, the United Arab Emirates, Sri Lanka, and internationally. Its healthcare verticals comprise hospitals, diagnostics, and day care specialty facilities. The company offers services in the areas of cardiac science, cosmetology, dental science, dermatology, diabetes/endocrinology, emergency medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, haematology, infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surgery, neurointerventional radiology, neurology, obstetrics and gynaecology, oncology, ophthalmology, orthopedics, pediatrics, physiotherapy and rehabilitation, plastic and reconstructive surgery, pulmonology, radiology, rheumatology, thoracic surgery, transplantation medicine, urology, and other support specialties. As of March 31, 2022, it operated a network of 26 hospitals with approximately 4,300 operational beds. The company also operates approximately 426 diagnostics centers and laboratories; and 2,550 collection centers. The company was incorporated in 1996 and is based in Gurugram, India.